no code implementations • 25 Jun 2018 • Benjamin A. Goldstein, Matthew Phelan, Neha J. Pagidipati, Rury R. Holman, Michael J. Pencina Elizabeth A Stuart
Our models suggested that the treatment effect for valsartan in our patient population was the same as in the trial, whereas for nateglinide treatment effect was stronger than observed in the original trial.